SBIR/STTR Research Award

CHEMILUMINESCENT LABELING AND DETECTION IN GELS

Award identifier 4e64ce7498b8df8214d8785a12fdf368de62ad9990cae0d2f698ea631b13460fAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
LUMIGEN, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

The objective of Phase I is to prepare a new family of chemiluminescent label compounds which can be conjugated to proteins and nucleic acids, subjected to electrophoresis and triggered to generate chemiluminescence in the gel. Successful development of the labeling compounds will permit the development of simple methods for direct detection in gels by eliminating membrane transfer and immunological binding protocols used in many techniques. The patented chemiluminescent technology involves reaction of the compounds with inexpensive chemical reagents. A prototypical compound produces visible chemiluminescence within an electrophoresis gel when conjugated to a protein. Additional chemiluminescent compounds emitting at distinct wavelengths spanning the visible spectrum will be synthesized and tested. Synthetic methods for conjugation will be established. Linkers for coupling to amine and thiol groups and a phosphoramidite linker are targeted. The chemiluminescence intensity, kinetics and spectrum of the chemiluminescent compounds will be evaluated. A key feature of the chemiluminescent reaction is that light is emitted as a 1-2 second burst when triggered in solution so that light intensity will be as high as possible when triggering is conducted within a gel. Detection sensitivity in solution and gel matrices will then be assessed using labeled analytes in model assays.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.